Smartleaf Asset Management
SRPT icon

Smartleaf Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Smartleaf Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.1K Buy
1,025
+666
+186% +$12.5K ﹤0.01% 2141
2026
Q2 		$6.11K Hold
359
– – ﹤0.01% 2605
2026
Q1 		$7.35K Sell
359
-189
-34% -$3.66K ﹤0.01% 2464
2025
Q4 		$11.8K Buy
548
+479
+694% +$10.1K ﹤0.01% 2320
2025
Q3 		$1.3K Sell
69
-63
-48% -$1.12K ﹤0.01% 2699
2025
Q2 		$2.26K Sell
132
-179
-58% -$7.64K ﹤0.01% 2304
2025
Q1 		$21.9K Sell
311
-131
-30% -$13.8K ﹤0.01% 1566
2024
Q4 		$53.6K Buy
442
+216
+96% +$26.5K 0.01% 1151
2024
Q3 		$28.1K Buy
226
+114
+102% +$15.8K ﹤0.01% 1154
2024
Q2 		$17.7K Buy
112
+57
+104% +$7.32K ﹤0.01% 1089
2024
Q1 		$7.16K Hold
55
– – ﹤0.01% 1101
2023
Q4 		$5.38K Buy
+55
New +$5.28K ﹤0.01% 853

Other funds holding SRPT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Smartleaf Asset Management's SRPT Position: Q3 2026 in Review

Smartleaf Asset Management increased its Sarepta Therapeutics (SRPT) stake by 186% in Q3 2026, buying an estimated $12.5K and bringing the position to 1,025 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Smartleaf Asset Management first reported a position in SRPT in Q4 2023 and has held it in 12 quarters since. The position peaked at $53.6K in Q4 2024. 159 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Smartleaf Asset Management held 1,025 shares of Sarepta Therapeutics worth $19.1K as of Q3 2026.
  • Smartleaf Asset Management bought 666 Sarepta Therapeutics shares in Q3 2026, an estimated $12.5K.
  • Sarepta Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2141 holding.
  • Smartleaf Asset Management first reported a position in Sarepta Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Smartleaf Asset Management's Sarepta Therapeutics position peaked at $53.6K in Q4 2024.
  • 159 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.